Motley Rice - Attorneys at Law
Navigation
Main navigation
Motley Rice represents clients across many areas.
Learn about the cases Motley Rice is actively representing clients in or cases that we've litigated previously.
Ozempic® users are filing lawsuits for vision loss, ileus, and other serious injuries.
Lawsuits allege talcum powder use is linked to reproductive organ cancer for women.
Lawsuits allege toxic heavy metals in baby food damage infants’ brain development.
Social media companies are being sued over alleged teenage mental health harms.
Meta is being sued for teenage mental health harms allegedly caused by Facebook and Instagram.
Women hurt by birth control drugs and devices may be eligible to sue over their injuries.
Studies link hair relaxers to uterine/ovarian cancer. Lawsuits seek to hold companies accountable.
Family members may have been eligible to file Camp Lejeune water contamination lawsuits.
People are filing gastroparesis lawsuits after using drugs like Ozempic®, Wegovy® and Mounjaro™.
While litigation can take years to complete from start to finish, our firm is always working for our clients, no matter how long it takes or how hard it gets.
Motley Rice attorneys and support personnel are dedicated to representing clients and working with co-counsel located throughout the United States and around the world.
Comprehensive, up-to-date news on the issues surrounding the litigation areas of Motley Rice LLC.
News, Learn about the latest happenings from lawsuits and other events impacting plaintiffs.
Motley Rice lawyers share their insights on litigation and more to inform people exploring their legal options.
This case is no longer active
Mirena IUD Lawsuits
The Legal Team
Mirena is an IUD device that must be inserted by a trained health care provider and is intended to provide contraceptive protection for up to five years. Unfortunately, thousands of women and their loved ones have reported experiencing serious and sometimes fatal side effects to the FDA following the use of Mirena.
Manufactured by New Jersey-based Bayer Healthcare Pharmaceuticals, the Mirena IUD (generically known as levonorgestrel) was approved by the FDA for intrauterine contraception in 2000 and is used by approximately 2 million women in the United States alone.
In May 2013, the New Jersey Supreme Court consolidated lawsuits filed in that state alleging that Bayer sold the Mirena IUD in an unsafe, defective and inherently dangerous condition. This decision followed a ruling one month earlier to consolidate federal court lawsuits before U.S. District Judge Cathy Seibel in New York federal court. These cases allege that the Mirena IUD can migrate and perforate the uterine wall.
Later in August 2014, the U.S. Judicial Panel on multidistrict litigation ruled that all Mirena cases alleging idiopathic intracranial hypertension (IIH) will be tried on an individual basis instead of in a consolidated group. The Mirena multidistrict litigation consolidated in New Jersey and New York was not affected by this decision.
After hearing an appeal of an earlier 2016 ruling granted by Judge Cathy Seibel, the U.S. Court of Appeals for the Second Circuit affirmed the dismissal of more than 1,000 claims in the MDL in October 2017. Several state claims continue to move forward.
Attorney Carmen Scott is co-lead counsel for the Mirena multidistrict litigation state court consolidation in New Jersey and is co-chair of the AAJ Mirena® IUD Litigation Group, and litigates claims for birth control related lawsuits. Motley Rice attorney Fred Thompson serves as co-lead counsel for the Mirena® multidistrict litigation in the U.S. District Court for the Southern District of New York.
Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death.